AAAAAA

   
Results: 1-9 |
Results: 9
In vitro metabolism of citalopram by monoamine oxidase B in human blood
Authors: Kosel, M Amey, M Aubert, AC Baumann, P
Citation: M. Kosel et al., In vitro metabolism of citalopram by monoamine oxidase B in human blood, EUR NEUROPS, 11(1), 2001, pp. 75-78
Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers
Authors: Eap, CB Bondolfi, G Zullino, D Savary-Cosendai, L Powell-Golay, K Kosel, M Baumann, P
Citation: Cb. Eap et al., Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers, J CL PSYCH, 21(3), 2001, pp. 330-334
Cytochrome P450 2D6 genotype and methadone steady-state concentrations
Authors: Eap, CB Broly, F Mino, A Hammig, R Deglon, JJ Uehlinger, C Meili, D Chevalley, AF Bertschy, G Zullino, D Kosel, M Preisig, M Baumann, P
Citation: Cb. Eap et al., Cytochrome P450 2D6 genotype and methadone steady-state concentrations, J CL PSYCH, 21(2), 2001, pp. 229-234
Interaction of psychotropic drugs with monoamine oxidase in rat brain
Authors: Gnerre, C Kosel, M Baumann, P Carrupt, PA Testa, B
Citation: C. Gnerre et al., Interaction of psychotropic drugs with monoamine oxidase in rat brain, J PHARM PHA, 53(8), 2001, pp. 1125-1130
Intracellular Mg++ concentrations in smooth and striated muscle cells in spontaneously hypertensive rats
Authors: Kisters, K Krefting, ER Kosel, M Rahn, KH Hausberg, M
Citation: K. Kisters et al., Intracellular Mg++ concentrations in smooth and striated muscle cells in spontaneously hypertensive rats, AM J HYPERT, 13(4), 2000, pp. 427-430
Cytochrome P-450 activities in human and rat brain microsomes
Authors: Voirol, P Jonzier-Perey, M Porchet, F Reymond, MJ Janzer, RC Bouras, C Strobel, HW Kosel, M Eap, CB Baumann, P
Citation: P. Voirol et al., Cytochrome P-450 activities in human and rat brain microsomes, BRAIN RES, 855(2), 2000, pp. 235-243
Pharmacokinetic consequences of a citalopram treatment discontinuation (vol 21, pg 263, 1999)
Authors: Voirol, P Rubin, C Bryois, C Kosel, M Buclin, T Baumann, P
Citation: P. Voirol et al., Pharmacokinetic consequences of a citalopram treatment discontinuation (vol 21, pg 263, 1999), THER DRUG M, 21(6), 1999, pp. 682-682
Pharmacokinetic consequences of a citalopram treatment discontinuation
Authors: Voirol, P Rubin, C Bryois, C Kosel, M Buclin, T Baumann, P
Citation: P. Voirol et al., Pharmacokinetic consequences of a citalopram treatment discontinuation, THER DRUG M, 21(3), 1999, pp. 263-266
Analysis of the enantiomers of citalopram and its demethylated metabolitesusing chiral liquid chromatography
Authors: Kosel, M Eap, CB Amey, M Baumann, P
Citation: M. Kosel et al., Analysis of the enantiomers of citalopram and its demethylated metabolitesusing chiral liquid chromatography, J CHROMAT B, 719(1-2), 1998, pp. 234-238
Risultati: 1-9 |